Tsingke maintains strict confidentiality commitments for all customers — comprehensive internal security policies, data access controls, and standard NDA frameworks are baseline services we provide to every client. As some projects enter highly competitive target spaces, critical patent windows, or high-compliance phases, certain teams require an even higher level of technical data isolation and access control.
All DNA sequences and primer information are stored exclusively on the client's local system
Design, optimization, and analysis workflows run entirely within the client's local automated environment
Tsingke personnel have no access to plaintext sequences at any point
Core R&D assets never enter a third-party production system
Production is initiated only after client-authorized temporary decryption
Sequence data connects directly to modified DNA synthesis equipment
Synthesis device operation logs are automatically purged — no traceable records remain
The production chain delivers: "only encrypted noise visible — no sequence, no trace"
Sequencing results are automatically aligned and analyzed internally
Only a Pass / Fail verdict is output — no raw sequence data returned
Sequencing data is automatically encrypted under the client's own cryptographic system upon instrument completion
QC pipeline delivers: "know the result, never see the content"
Plasmids / bacterial stocks held for a maximum of 30 days, with supervised destruction available on demand
Storage area under 24/7 surveillance — clients can monitor sample status remotely in real time
Physical-layer controls prevent long-term retention and leakage risk
VH/VL variable regions and phage screening sequences determine binding specificity — the most critical IP in lead antibody development, typically within a patent protection window.
Patent Window
CAR structural domain combinations, co-stimulatory molecules, and vector optimization elements are the core assets of CGT programs. Frequent synthesis during functional validation makes confidentiality most critical here.
High-Frequency Synthesis
siRNA coding templates, sgRNA scaffolds, U6 promoters, and shRNA vectors encode target selection, expression efficiency, and off-target control strategies — priority pipeline assets.
Pipeline Protection
Key enzyme genes, regulatory elements, and expression frameworks of industrial strains are core differentiators that patents cannot fully cover. First-mover advantage depends on sequence confidentiality.
First-Mover Edge
Candidate mutation libraries reflect model prediction logic and iteration direction — the externalization of platform core capabilities. Data sovereignty requirements are highest here.
Data Sovereignty
Download the order form right and email it to info@tsingke.com.cn, or "Send Your Request" to submit your inquiry online.
Stay updated with the latest industry news and expert insights.
Subscribe now to receive:
● Industry updates
● Exclusive expert insights and analysis
Enter your email to stay ahead!
